CONMED Corporation  

(Public, NASDAQ:CNMD)   Watch this stock  
Find more results for Dirk Kuyper
47.65
-0.56 (-1.16%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 47.15 - 48.88
52 week 29.95 - 49.10
Open 48.20
Vol / Avg. 474,656.00/205,048.00
Mkt cap 1.30B
P/E 37.45
Div/yield 0.20/1.68
EPS 1.27
Shares 27.21M
Beta 1.22
Inst. own 101%
May 22, 2014
Conmed Corp Annual Shareholder Meeting - 3:30PM EDT - Add to calendar
Apr 24, 2014
Q1 2014 CONMED Earnings Conference Call - 10:00AM EDT - Add to calendar
Apr 24, 2014
Q1 2014 CONMED Earnings Release - 9:30AM EDT - Add to calendar
Apr 8, 2014
CONMED at Needham Healthcare Conference - Webcast
Mar 11, 2014
CONMED at Canaccord Genuity's Musculoskeletal Conference - Webcast
Feb 13, 2014
Q4 2013 CONMED Earnings Conference Call - Webcast
Feb 13, 2014
Q4 2013 CONMED Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 5.03% 4.71%
Operating margin 7.95% 7.37%
EBITD margin - 15.71%
Return on average assets 3.77% 3.31%
Return on average equity 6.84% 5.92%
Employees 3,600 -
CDP Score - -

Address

525 FRENCH ROAD
UTICA, NY 13502
United States - Map
+1-315-6243215 (Phone)
+1-315-7970321 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

CONMED Corporation (CONMED) is a medical technology company/ The Company emphasizes on surgical devices and equipment for minimally invasive procedures and monitoring. The Company's products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The Company operates in five segments: CONMED Endoscopic Technologies, CONMED Endosurgery, CONMED Electrosurgery, CONMED Linvatec and CONMED Patient Care. The Company offers a range of devices and products for uses in arthroscopic surgery. The Company's powered instruments product line includes the MPower battery system. The Company's patient care product line includes a line of vital signs and cardiac monitoring products, including pulse oximetry equipment and sensors, electrocardiogram (ECG) electrodes and cables, cardiac defibrillation and pacing pads and blood pressure cuffs.

Officers and directors

Mark E. Tryniski Chairman of the Board
Age: 52
Bio & Compensation  - Reuters
Joseph J. Corasanti President, Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert D. Shallish Jr. Chief Financial Officer, Executive Vice President - Finance, Assistant Secretary
Age: 64
Bio & Compensation  - Reuters
Daniel S. Jonas Executive Vice President - Legal Affairs, General Counsel
Age: 49
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Luke A. Pomilio Executive Vice President, Corporate General Manager, Controller
Age: 48
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Heather L. Cohen Executive Vice President - Human Resources, Deputy General Counsel, Secretary
Age: 40
Bio & Compensation  - Reuters
William W. Abraham Executive Vice President - Business Development
Age: 81
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joseph G. Darling Executive Vice President - Corporate Commercial Operations
Age: 55
Bio & Compensation  - Reuters
Gregory Renard Jones Executive Vice President - Quality Assurance/Regulatory Affairs
Age: 58
Bio & Compensation  - Reuters
Brian P. Concannon Director
Age: 55
Bio & Compensation  - Reuters